The Latest Breaking News from FDA

Three states are asking a judge to let them try a new approach with a lawsuit to force the federal government to reduce access to the abortion pill mifepristone

Hims stock rallied almost 22% over two days on enthusiasm after the FDA said it will allow compounded versions of Lilly's obesity drug.

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

Hot food preparation was shut down following an inspection

Conservative ‘wishlist’ of policies for a future Trump administration goes so far as transforming food and farming

Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.

FDA reports shortage of crucial IV drugs due to Hurricane Helene impact on manufacturer, leading to supply gaps and healthcare disruptions.

An initial recall of eggs produced by a Wisconsin-based farm was issued on Sept. 6

A new FDA rule requires that screenings inform people if they have a high ratio of dense breast tissue. Experts say it’s just one step toward awareness